BioProcess Insider figuratively sat down with bioprocess veteran Roger Lias, as the new chief commercial officer of Vibalogics, to discuss his different experiences and predictions for the CDMO market. Lias has served in senior roles at Diosynth, Lonza, KBI Biopharma, Cytovance Biologics and Eden Biologics. More recently Lias served as chief executive officer at Avid Bioservices before joining Indian drugmaker Stelis Biopharma, where he was responsible for transitioning its manufacturing models. His latest career move takes him to US and…
